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Abstract It has been shown previously that DNA binds and
inhibits neutrophil elastase (NE). Here we demonstrate that
DNA has a better affinity for neutrophil cathepsin G (cat G)
than for NE and is a better inhibitor of cat G than of NE.
DNase-generated 6 0.5 kb DNA fragments inhibit NE and cat
G as potently as full length DNA. This rationalises our
observation that administration of DNase to cystic fibrosis
patients does not enhance the NE and cat G activity of their lung
secretions. Neutrophil proteinase 3 is not inhibited by DNA and
might thus be the most harmful proteinase in inflammatory lung
diseases.
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1. Introduction
The azurophil granules of neutrophils store neutrophil elas-
tase (NE), neutrophil cathepsin G (cat G) and neutrophil pro-
teinase 3 (PR3), three serine proteinases which are able to
cleave lung extracellular matrix proteins such as elastin, col-
lagen, ¢bronectin and laminin and to cause extensive lung
tissue damage in the animal [1]. NE is thought to play a major
role in the pathogenesis of the pulmonary manifestation of
cystic ¢brosis [2]. In this disease excessive phagocytosis and
cell death of neutrophils lead to a permanent release of gran-
ule proteinases and nuclear DNA [2]. The latter binds and
partially inhibits NE in vitro [3,4] and may therefore partially
restore the antielastase defence of airways secretions. It is not
known whether DNA also inhibits cat G and PR3.
Cystic ¢brosis is characterised by an accumulation of vis-
cous secretions which contribute to the bacterial colonisation
of airways. Since neutrophil-derived DNA is a major contrib-
utor to this viscosity, patients are now treated with aerosols of
DNase which improve their lung function [5]. This treatment
depolymerises the airways DNA down to an average size of
about 0.4 kb [6]. A number of investigators have measured the
activity of NE in cystic ¢brosis lung secretions in the course of
DNase therapy [7^10]. These studies gave, however, con£ict-
ing results some of which have been analysed in an editorial
review by Vogelmeier and Do«ring [11]. Thus, it is not yet
unambiguously established whether the DNase-promoted de-
polymerisation of DNA dissociates the in vivo formed DNA^
NE complexes and thus increases the NE activity of airway
secretions.
The present work was undertaken (i) to see whether DNA
binds and inhibits cat G and PR3 in addition to NE and (ii)
to study the inhibition of these proteinases by DNase-gener-
ated DNA fragments.
2. Materials and methods
2.1. Materials
NE and cat G were isolated and active site titrated as described
previously [12]. PR3 was purchased from A.R.T. Athens, GA, USA.
Mucus proteinase inhibitor was a gift from Novartis, Switzerland.
DNase was from Ho¡man-La Roche, Switzerland. Remazolbrilliant
blue-labelled elastin came from E.P.C. Owenville, MO, USA. DNA-
cellulose, proteinase K, RNase and chymostatin were from Sigma, St.
Louis, MO, USA while Zincov came from Calbiochem-Novabiochem,
San Diego, CA, USA. Bu¡er A is composed of 50 mM HEPES,
150 mM NaCl, pH 7.4. The lung secretions collected before and after
inhalation of 2.5 mg of DNase were stored frozen.
2.2. Electrophoresis and chromatography
Lung secretions were incubated for 3 h at 50‡C with 0.5% SDS, 100
Wg/ml proteinase K, 20 Wg/ml RNase and 5 mM EDTA. DNA was
then extracted using phenol:chloroform:isoamylic alcohol (25:24:1)
and precipitated with ethanol [13]. The pellet was dissolved in bu¡er
A and kept frozen. Electrophoresis was carried out on a 0.5% agarose
gel stained with ethidium bromide. A 500 bp ladder from Appligene,
France, and a lambda DNA-HindIII digest from Amersham-Pharma-
cia, Sweden were used as size markers. Chromatography on DNA-
cellulose was done as before [4].
2.3. Elastolytic activity
The elastolytic activity was measured at 37‡C in bu¡er A as de-
scribed previously [4]. Mixtures of proteinases and inhibitors were
incubated for 15 min at 25‡C before assay. Lung secretion extracts
were prepared as follows: 1 g of frozen secretion was mixed with 1 ml
of bu¡er A containing 1 mM Zincov, gently homogenised for 10 min
at 0‡C using a Potter device and centrifuged at 10 000Ug during
30 min at 4‡C. The elastolytic activity of the supernatants was then
assayed in duplicate. Zincov, a potent metalloproteinase inhibitor [14]
was used to inhibit zinc-containing metalloproteinases such as Pseu-
domonas aeruginosa elastase [15] and type IV collagenase [16,17] which
may contribute to the elastolytic activity of lung secretions.
3. Results and discussion
3.1. A⁄nity chromatography on DNA-cellulose
At low ionic strength (50 mM HEPES, pH 7.4) NE and cat
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G were bound on DNA-cellulose whereas PR3 was eluted
unretarded from the column. A linear NaCl gradient eluted
NE as a symmetrical peak whose top corresponded to 160
mM NaCl. Thus, with the physiological bu¡er used in this
paper, the a⁄nity of DNA for NE is low. In contrast, cat G
bound so tightly to the column that it could not be eluted
from it, indicating that it interacts very strongly with DNA.
The fact that cat G, NE and PR3 have a decreasing order of
a⁄nity for DNA is in accordance with their decreasing cati-
onic character as evidenced by electrophoresis [18].
3.2. E¡ect of in vitro generated DNA fragments on the
elastolytic activity of pure NE, cat G and PR3
Fig. 1 shows that full length DNA partially inhibits the
elastolytic activity of NE (37 þ 2% inhibition) and cat G
(67 þ 2% inhibition) but has no e¡ect on the elastolytic activ-
ity of PR3. When DNA was incubated with DNase for var-
iable periods of time prior to its reaction with the proteinases,
its proteinase inhibiting activity did not change (Fig. 1)
although its size considerably decreased (6 0.5 kb, see Fig.
2). Low molecular mass DNA fragments are therefore as e⁄-
cient as full length DNA in inhibiting NE and cat G.
3.3. E¡ect of in vivo DNA fragmentation on the elastolytic
activity of NE, cat G and PR3
DNase therapy considerably depolymerises DNA in cystic
¢brosis lung secretions, the average DNA size being about 0.4
kb [6]. We wanted to know whether the in vivo hydrolysis of
DNA by DNase may partially release neutrophil proteinases
from their nucleoprotein complexes. To this end, we designed
a speci¢c assay of NE, cat G and PR3 using elastin as a
substrate in the absence or presence of mucus proteinase in-
hibitor, a protein that inhibits NE and cat G but not PR3 or
chymostatin, a speci¢c inhibitor of cat G [1]. Preliminary ex-
periments were done with pure enzymes. Table 1 shows that
indeed mucus proteinase inhibitor does not inhibit PR3 while
chymostatin speci¢cally inhibits cat G. On the other hand, the
elastolytic activities of the mixtures (NE+cat G+PR3) þ inhib-
itor correspond to the sum of the activities of the individual
enzymes þ inhibitor. Thus, the elastolytic activity of Zincov-
containing lung secretions (see Section 2) in the absence and
presence of mucus proteinase inhibitor or chymostatin allows
separate measurement of the activity of NE, cat G and PR3.
Fig. 1. Elastolytic activity of NE (A), cat G (B) and PR3 (C) in the
presence of native DNA (time 0) and of DNA digested for variable
periods of time with DNase. The digestion was done by incubating
2 mg/ml DNA with 0.2 WM DNase at 25‡C in bu¡er A+1 mM
CaCl2+1 mM MgCl2 [20]. After addition of 2.5 mM EDTA to stop
the digestion, the fragmented DNA was mixed with proteinase and
the elastolytic activity was measured. ‘E’ = NE, cat G or PR3 con-
trol without DNA. The ¢nal proteinase and DNA concentrations
were 1 WM and 1 mg/ml, respectively. The elastolytic activities re-
ported in the ¢gure are the mean values resulting from triplicate
runs. The standard errors (96%) were too small to be reported on
the top of the activity bars.
Fig. 2. Electrophoresis and ethidium bromide staining of DNA di-
gested for variable periods of time with DNase and ethidium bro-
mide staining. Lanes 1 and 9, molecular size markers: 500 bp ladder
(lane 1) and lambda DNA-HindIII digest (lane 9). Lane 2: native
DNA. Lanes 3^8: DNA digested for 5, 10, 20, 30, 45 and 60 min
under the conditions given in the legend to Fig. 1.
Table 1
Elastolytic activity (Wg elastin solubilised/ml/min) of 0.1 WM pure
NE, cat G or PR3 in the absence or presence of 80 WM mucus pro-
teinase inhibitor or 100 WM chymostatin
Inhibitors Proteinases
NE cat G PR3 NE+cat G+PR3
None 0.97 0.14 0.36 1.49
Mucus proteinase inhibitor 0 0 0.33 0.37
Chymostatin 0.90 0 0.34 1.36
The ¢gures are average values of 3^4 assays. The reproducibility of
the technique was measured by repeating the same assay 6^8 times
and calculating the relative coe⁄cient of variation (standard devia-
tion/meanU100). This parameter was found to lie between 3 and
4%.
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The measurements were done on 18 lung secretions col-
lected before and 30 min after DNase inhalation. There
were no systematic increases but rather random variations
in NE and cat G activities following DNase administration.
PR3 which is not inhibited by DNA, underwent similar var-
iations. Table 2 shows that these variations are not statistical-
ly signi¢cant. The lack of e¡ect of DNase was con¢rmed by ex
vivo experiments showing that the elastolytic activity of a
number of cystic ¢brosis lung secretions was not enhanced
following 1 h reaction with 0.2 WM DNase, a concentration
close to that found in lung secretions following DNase ther-
apy [19]. Altogether, the above data con¢rm the in vitro ob-
servation that small DNA fragments inhibit NE and cat G as
potently as full length DNA.
4. Conclusion
We conclude that DNA has a bene¢cial e¡ect on the pro-
teolytic potential of cystic ¢brosis lung secretions since it
blocks about 40% of the elastolytic activity of NE and 70%
of that of cat G. This bene¢cial e¡ect is not lost following
DNase administration. PR3, which is not inhibited by DNA,
might be more deleterious to the lung than the other two
enzymes.
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Table 2
Mean elastolytic activity of NE, cat G and PR3 in the lung secre-
tions of 18 cystic ¢brosis patients before and 30 min after DNase
inhalation
NE cat G PR3
Before DNase 52 þ 8 5.8 þ 0.8 5.2 þ 1.0
30 min after DNase 58 þ 12 5.1 þ 1.5 5.7 þ 1.1
The activities are expressed in Wg elastin solubilised/ml/min. The ¢g-
ures are means þ S.E.M. The di¡erences between before and after
DNase were not signi¢cant (Wilcoxon signed rank test, Ps 0.9).
FEBS 23645 8-5-00
J. Duranton et al./FEBS Letters 473 (2000) 154^156156
